Spinal cord stimulator claims: who can file and what to do

If a spinal cord implant from Boston Scientific, Abbott or Nevro hurt you, you may have a claim. Each maker’s cases are now with one federal judge.

See If You Qualify

Free · No obligation · About 2 minutes

Does this case involve physical injury, a medical diagnosis, or significant financial loss? *

Updated 16 sources

This may apply to you if

  • You have or had a Boston Scientific, Abbott or Nevro spinal cord stimulator.
  • You had a problem such as shocks, burns, a lead that moved, nerve injury or loss of pain relief.
  • You can get records that show the device and your care.

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

Legal case files and documents on a desk (photo illustration)
Photo illustration

The short answer

Who may qualify?
You may be able to file a claim if a Boston Scientific, Abbott or Nevro spinal cord implant hurt you. People who sued report shocks and burns. Others say wires moved or pain did not get better. [3]
What is happening in the case right now, and what does that mean for someone new?
Each maker now has its own group of cases before one federal judge. The Boston Scientific group began in June 2026. The Abbott and Nevro groups began on October 2, 2026. [2]
What could I get?
No one has announced how much each person could get. The court orders read for this page do not list any payments. [2]
What does it cost to get help?
Ask for the fee terms in writing before you hire a lawyer. Ask what you would owe if you get no money. [15]

Who qualifies

Do you qualify?

  • You have or had a Boston Scientific, Abbott or Nevro spinal cord stimulator.
  • You had a problem such as shocks, burns, a lead that moved, nerve injury or loss of pain relief.
  • You can get records that show the device and your care.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

Matthew F. Kennelly · United States Judicial Panel on Multidistrict Litigation · Acting Chair of the Judicial Panel on Multidistrict Litigation for the MDL 3181 transfer order

Finding: On June 5, 2026, the Panel sent the Boston Scientific spinal cord stimulator cases to Judge Josephine L. Staton in the Central District of California and declined to create one group for every maker. It said judging the preemption defense was beyond its authority.

JPML Transfer Order, MDL No. 3181 (Boston Scientific SCS), filed June 5, 2026 (opens in a new tab) · Jun 5, 2026 · Checked Oct 5, 2026

Karen K. Caldwell · United States Judicial Panel on Multidistrict Litigation · Chair of the Judicial Panel on Multidistrict Litigation for the MDL 3194 and MDL 3195 transfer orders

Finding: On October 2, 2026, the Panel created separate groups for Abbott cases before Judge Lindsay C. Jenkins in the Northern District of Illinois and Nevro cases before Judge Haywood S. Gilliam, Jr. in the Northern District of California. It found common questions despite varied injuries.

JPML Transfer Order, MDL No. 3194 (Abbott SCS), filed October 2, 2026 (opens in a new tab) · Oct 2, 2026 · Checked Oct 5, 2026

Antonin Scalia · Supreme Court of the United States · Justice who wrote the opinion of the Court in Riegel v. Medtronic, Inc.

Finding: The Court held that federal law bars state common-law claims challenging the safety or effectiveness of a device marketed in a form that received FDA premarket approval. It said states may still provide damages for claims premised on violating FDA regulations.

Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), U.S. Reports via GovInfo (opens in a new tab) · Feb 20, 2008 · Checked Oct 5, 2026

U.S. Food and Drug Administration · Publisher of the 2020 letter to health care providers on spinal cord stimulators

Finding: The agency told providers to confirm pain relief with a trial before a permanent implant and to give patients the device maker, model and unique device identifier. It said adverse event reports alone cannot show how often problems occur or prove cause.

FDA, Conduct a Trial Stimulation Period Before Implanting a Spinal Cord Stimulator (SCS) – Letter to Health Care Providers (FDA.gov archive) (opens in a new tab) · Sep 3, 2020 · Checked Oct 5, 2026

Sanket S. Dhruva · University of California, San Francisco School of Medicine · First-listed author of the 2023 JAMA Neurology study

Finding: In insurance records, 17.9% of 1,260 people with a stimulator had a device-related complication within two years and 22.1% had revisions or removals, not always for complications.

Dhruva SS et al., Long-term outcomes ... of spinal cord stimulators compared with conventional medical therapy for chronic pain, JAMA Neurol 2023 (PMID 36441532) (opens in a new tab) · Jan 1, 2023 · Checked Oct 5, 2026

The evidence and its limits

U.S. Food and Drug Administration · 2020

Conduct a Trial Stimulation Period Before Implanting a Spinal Cord Stimulator (SCS): FDA review of medical device reports

Design:
Agency review
Participants:
Not an enrolled study: 107,728 medical device reports received July 27, 2016 to July 27, 2020.
Finding:
The most common reported patient problem was inadequate pain relief (28.1% of reports); common device problems included charging problems, impedance changes and lead migration.
Main limitation
Reports can be incomplete or unverified and cannot show how often problems occur or prove the device caused them. The live FDA page has moved; the read copy is FDA’s official web archive.

Read the source: Conduct a Trial Stimulation Period Before Implanting a Spinal Cord Stimulator (SCS): FDA review of medical device reports (opens in a new tab) · Checked Oct 5, 2026

Institute for Musculoskeletal Health, The University of Sydney · Cochrane Database of Systematic Reviews · 2023

Spinal cord stimulation for low back pain

Design:
Meta-analysis
Participants:
13 studies with 699 participants with chronic low back pain
Finding:
Moderate-certainty evidence from one 50-person trial suggests SCS probably does not improve back or leg pain more than placebo at six months; repeat surgery and lead migration were among reported harms.
Main limitation
Covers low back pain only, with few long-term placebo-controlled data and poorly reported harms. It does not show what caused any one person’s injury.

Read the source: Spinal cord stimulation for low back pain (opens in a new tab) · Checked Oct 5, 2026

University of California, San Francisco; Optum Labs · JAMA Neurology · 2023

Long-term Outcomes in Use of Opioids, Nonpharmacologic Pain Interventions, and Total Costs of Spinal Cord Stimulators Compared With Conventional Medical Therapy for Chronic Pain

Design:
Cohort
Participants:
7,560 propensity-matched insured adults, including 1,260 treated with a spinal cord stimulator
Finding:
17.9% of stimulator patients had device-related complications within two years and 22.1% had revisions or removals; stimulators were not linked to less opioid use at two years.
Main limitation
Retrospective insurance-claims data; an association study that cannot show why each complication or removal happened, and not all removals were for complications.

Read the source: Long-term Outcomes in Use of Opioids, Nonpharmacologic Pain Interventions, and Total Costs of Spinal Cord Stimulators Compared With Conventional Medical Therapy for Chronic Pain (opens in a new tab) · Checked Oct 5, 2026

Pain Medicine journal authors (Eldabe, Buchser, Duarte) · Pain Medicine · 2016

Complications of Spinal Cord Stimulation and Peripheral Nerve Stimulation Techniques: A Review of the Literature

Design:
Other study design
Participants:
Narrative literature review; no pooled participant count stated in the abstract
Finding:
Complications were reported in 30% to 40% of patients; lead migration was the most common hardware problem and serious nerve damage was rare.
Main limitation
A narrative review that combines spinal cord and peripheral nerve stimulation and predates current device models; it does not measure any one maker’s devices.

Read the source: Complications of Spinal Cord Stimulation and Peripheral Nerve Stimulation Techniques: A Review of the Literature (opens in a new tab) · Checked Oct 5, 2026

What this stage means for you

Each maker’s cases are grouped before one federal judge for pretrial work. This does not decide any one person’s claim.

What rules a case out

Not covered by this case

  • The three court groups are for Boston Scientific, Abbott and Nevro devices.
  • A recall or a lawsuit does not mean your device must come out. Talk to your doctor before you change, turn off or remove it.
  • This page does not give a diagnosis, a removal plan or your filing deadline.

What it costs

Lawyer fee
Ask for the written agreement.

A contingent fee agreement should be signed by you and state the percentage and how costs are taken out.

Source: ABA Model Rule 1.5: fees · as of Oct 5, 2026

Case expenses
Ask which costs are separate.

The agreement should say which expenses you owe even if you do not win.

Source: ABA Model Rule 1.5: fees · as of Oct 5, 2026

Your medical records
Ask about copying and mailing charges.

Providers may charge reasonable copying and mailing costs, but not a search or retrieval fee.

Source: HHS: Your medical records · as of Oct 5, 2026

What happens step by step

  1. Find your device record

    Ask your doctor or hospital for the maker, model and unique device identifier (UDI).

    Source: FDA letter to health care providers on spinal cord stimulators, 2020 (FDA archive) · as of Oct 5, 2026

  2. Gather your care records

    Request records of the trial, the implant surgery, setting changes and any later surgery.

    Source: HHS: Your medical records · as of Oct 5, 2026

  3. Read the fee terms

    Check the percentage, the costs and what you owe if there is no recovery before you sign.

    Source: ABA Model Rule 1.5: fees · as of Oct 5, 2026

Who may qualify?

People with a Boston Scientific, Abbott or Nevro spinal cord stimulator who were hurt may be able to file a claim. The people who sued describe shocks, burns, leads that moved, nerve injuries and pain relief that failed. A problem alone does not prove the device was at fault.

What a spinal cord stimulator is

A spinal cord stimulator is an implant that sends electrical signals to the spinal cord to ease pain. Thin wires called leads carry the signals from a battery-powered unit. Doctors offer it for long-lasting pain in the back, arms or legs, such as pain that remains after back surgery. In 2020 the FDA estimated that about 50,000 are implanted each year.

Doctors usually test a temporary device first, often for 3 to 7 days. The FDA has told doctors to place a permanent device only after a trial shows enough pain relief. Some people later need more surgery to fix, move or remove parts. A lawyer will usually want to know the brand, the model and what went wrong.

What is happening in the case right now, and what does that mean for someone new?

A panel of federal judges has sent each maker’s cases to its own judge. The Boston Scientific group started on June 5, 2026, and the Abbott and Nevro groups started on October 2, 2026. Each group handles pretrial work together, but each person’s injury and cause are still looked at one by one.

Boston Scientific (MDL 3181)

Judge Josephine L. Staton of the federal court for central California leads this group. On October 1, 2026, the panel’s report listed 41 pending cases in it. The people who sued say Boston Scientific won approval using studies of other companies’ devices. They say it then changed its devices through a chain of approval updates to avoid closer review and new testing.

They also say company sales staff helped place leads and set up devices during surgery. They call that practicing medicine without a license. The order that created the group does not name any device models.

Separately, Boston Scientific told customers in June 2026 to stop using unused Infinion CX leads, models SC-2317-50 and SC-2317-70. The FDA notice says stress where the lead is anchored may cause breaks or weak stimulation. It says the recall does not affect leads already implanted, and it advises no extra checks beyond routine follow-up. The court order read here does not mention this recall.

Abbott (MDL 3194)

Judge Lindsay C. Jenkins of the federal court for northern Illinois leads this group. The order said 26 cases were pending in 13 federal court districts when it was signed. The people who sued say Abbott used approval updates to bring out changed devices without new testing, and did not warn about risks.

Those asking for the group named three common injuries: nerve injury from electric current, tissue damage from overheating and failed leads. Almost all say Abbott sales staff programmed or adjusted devices, often with no doctor present. The order does not name any device models.

Nevro (MDL 3195)

Judge Haywood S. Gilliam, Jr., of the federal court for northern California leads this group. The order said 23 cases were pending in 10 federal court districts. The companies named are Nevro, now called Nevro LLC, and Globus Medical.

The people who sued describe shocks, incontinence (loss of bladder or bowel control) and leg weakness from the electric signals. They also describe burns and leads that moved, and devices that did not relieve pain. Two cases involve the HFX iQ device and claim a design flaw. Almost all say sales staff changed settings or moved leads, and were trained to make misleading statements.

Other brands

In June 2026 the panel chose not to put every maker’s cases into one group. It said each maker has its own devices and its own approval history. Some related cases named Medtronic, but these orders did not create a Medtronic group. If you have another brand, a lawyer can tell you what options apply.

Can federal law block these claims?

It can block some kinds of claims. The devices in these cases went through the FDA’s strictest review, called premarket approval. In 2008 the Supreme Court held that federal law bars many state claims that challenge the safety of a device sold as approved. It also said claims based on a company breaking FDA rules are not barred in the same way.

Lawyers call this preemption, which means federal law overrides state law. The companies are raising this defense, and the panel expects it to be argued in each group. The people who sued focus on claims that the companies broke FDA rules, such as rules for changing approved devices. Some also sued the FDA, saying it did not check the changes closely or act on safety reports.

The panel said it could not decide who is right on this question. That question is for the judges handling the cases. Ask a lawyer how those rulings may affect your claim.

What could I get?

No one has announced how much each person could get. The court orders read for this page do not announce any payment or deal. Past results in other cases do not promise a similar result.

If money is recovered, the lawyer’s fee and case costs may be taken out first. Your written fee agreement should say whether costs come out before or after the fee.

What does it cost to get help?

A lawyer may charge a share of any money recovered, called a contingent fee. That agreement should be in writing and signed by you. It should give the percentage, the costs that come off the top and any costs you owe if you lose.

Copies of your own records may come with a reasonable charge for copying and mailing. A provider cannot charge you for searching for your records. It also cannot refuse copies because you have an unpaid bill.

Is there a deadline?

Yes, but it depends on your state and your claim. The time limit comes from the law that covers each type of claim. A lawyer can check which one applies to you.

Deadlines for injury claims often turn on dates, such as when the device was placed and when you learned what may have caused the harm. Write down those dates, even if you are not sure of some. If you already filed a case or signed with a firm, tell any new lawyer.

What should I do today?

Talk to your doctor before you turn off, change or remove your device. Then gather records that show the device and what happened. Do not sign with two law firms for the same claim.

Records that help

Ask for the device maker, the model and the unique device identifier, or UDI. The FDA has asked doctors to give patients this information. Gather records from the trial period, the implant surgery and any later surgery to fix, move or remove parts.

Keep notes on each visit when someone changed your settings, including company staff. Save records of burns, shocks, emergency visits and scans. You have a right to copies of your medical and billing records from most providers and health plans.

You can report a problem with your device to the FDA through MedWatch. Tell your doctor too, so they can check the device.

What happens after I check?

First, list your device, your dates and your problems. Next, a lawyer can look at whether your case fits one of the court groups and which time limit applies. Then you decide whether to sign a written fee agreement.

Checking does not file a case for you. Before you share files, ask who will receive them and how they will be used.

What is the evidence that the product causes this?

Studies and FDA reports show these devices can have problems, but they cannot show what caused any one person’s injury. A 2023 review of trials found little proof of lasting benefit for low back pain. Other studies found that complications and repeat surgeries were common. The FDA has also said the devices give many patients a chance at real relief, so talk to your doctor about your own device.

From July 2016 to July 2020, the FDA received 107,728 reports about stimulators used for pain. Pain relief that was not good enough was the most common patient problem in those reports. Charging problems and leads that moved were among the most common device problems. The FDA said these reports cannot show how often problems happen or prove that a device caused them.

Researchers at the University of Sydney pooled 13 trials with 699 people with low back pain. They found the device probably does not improve pain more than a fake device at six months, but that finding came from one small trial. In one trial, 13 of 42 people needed repeat surgery within two years.

A 2023 study led by a University of California, San Francisco doctor used insurance records for 1,260 people with a stimulator. Within two years, about 18% had a device-related complication, and about 22% had the device revised or removed. Not every removal was for a complication, and the study cannot show why each problem happened.

A 2016 review of published research found that 30% to 40% of patients had at least one complication. Lead migration, when a lead moves out of place, was the most common hardware problem. Serious nerve damage was rare.

Questions people ask

These questions cover recalls, removal, other brands and claims against the FDA. They do not replace advice from your doctor or a lawyer.

Sources

The sources below include the federal panel’s orders, FDA notices, a Supreme Court decision and published studies. Each one is linked so you can read it yourself.

Questions people ask

Do I need to have my stimulator removed to file a claim?

It depends. Ask a qualified medical provider about your spinal cord stimulator health question. The public source reviewed here can identify known warnings or reported issues, but it cannot diagnose you or decide causation. Keep diagnosis, treatment, and product records for a lawyer to review.

Source: FDA: Boston Scientific Infinion CX Lead Recall · as of Oct 7, 2026

My stimulator part was recalled. Does that mean I have a case?

It depends on your facts and the deadline that applies. The public spinal cord stimulator source reviewed here does not decide any one person's eligibility or filing deadline. A lawyer can check your records, dates, and state law before you rule yourself out.

Source: FDA: Boston Scientific Infinion CX Lead Recall · as of Oct 7, 2026

I have a Medtronic or other brand of stimulator. Can I still ask?

It depends. Ask a qualified medical provider about your spinal cord stimulator health question. The public source reviewed here can identify known warnings or reported issues, but it cannot diagnose you or decide causation. Keep diagnosis, treatment, and product records for a lawyer to review.

Source: FDA: Boston Scientific Infinion CX Lead Recall · as of Oct 7, 2026

I had stimulators from more than one maker. What happens?

It depends. Ask a qualified medical provider about your spinal cord stimulator health question. The public source reviewed here can identify known warnings or reported issues, but it cannot diagnose you or decide causation. Keep diagnosis, treatment, and product records for a lawyer to review.

Source: FDA: Boston Scientific Infinion CX Lead Recall · as of Oct 7, 2026

Why did some people also sue the FDA?

Some lawsuits alleged Administrative Procedure Act claims against FDA, challenging whether spinal cord stimulators went through the proper regulatory approval process and whether federal preemption applied. That does not mean FDA caused an individual injury or that every stimulator claim includes FDA. A lawyer can explain which defendants and claims fit a specific record.

Source: D. Md. order in spinal cord stimulator litigation, May 21, 2026 · as of Oct 7, 2026

Where can I report a problem with my stimulator?

You can report a device problem to FDA through MedWatch. FDA uses reports to monitor device safety, but a report does not prove a legal claim. Tell your treating clinician about symptoms or device changes as well.

Source: FDA MedWatch · as of Oct 7, 2026

Which records should I gather for a spinal cord stimulator review?

Gather records that show dates, products or accounts, symptoms or losses, and any official reports tied to the spinal cord stimulator issue. These records help a lawyer understand the facts, but they do not prove a claim by themselves. Ask what else is needed before sending private material.

Source: FDA: Boston Scientific Infinion CX Lead Recall · as of Oct 7, 2026

How does the deadline work for a spinal cord stimulator question?

There is no one deadline that this FAQ can apply to every spinal cord stimulator situation. Filing deadlines can depend on the law, the type of claim, and the facts of the case. A lawyer can check which rule applies before you rule yourself out.

Source: S.D.N.Y.: How long do I have to file my complaint? · as of Oct 7, 2026

Stay informed

Get free updates about Spinal cord stimulator claims: who can file and what to do

No phone call required. We will email you about relevant court filings, settlements, or important deadlines.

By submitting, you agree to receive email updates about this case. You can unsubscribe anytime. This is not legal advice, and we are not a law firm.

Sources

  1. JPML transfer order, MDL 3181, June 5, 2026JPML transfer order, MDL 3181, June 5, 2026 · court
  2. JPML transfer order, MDL 3194, October 2, 2026JPML transfer order, MDL 3194, October 2, 2026 · court
  3. JPML transfer order, MDL 3195, October 2, 2026JPML transfer order, MDL 3195, October 2, 2026 · court
  4. JPML pending MDL report by actions, October 1, 2026JPML pending MDL report by actions, October 1, 2026 · court
  5. JPML pending MDL report by MDL number, October 1, 2026JPML pending MDL report by MDL number, October 1, 2026 · court
  6. FDA letter to health care providers on spinal cord stimulators, 2020 (FDA archive)FDA letter to health care providers on spinal cord stimulators, 2020 (FDA archive) · regulator
  7. FDA recall notice: Boston Scientific Infinion CX leadFDA recall notice: Boston Scientific Infinion CX lead · regulator
  8. FDA: What is a medical device recall?FDA: What is a medical device recall? · regulator
  9. FDA: Premarket approval (PMA)FDA: Premarket approval (PMA) · regulator
  10. Riegel v. Medtronic, 552 U.S. 312 (2008)Riegel v. Medtronic, 552 U.S. 312 (2008) · regulator
  11. Traeger et al., Cochrane review, 2023Traeger et al., Cochrane review, 2023 · study
  12. Dhruva et al., JAMA Neurology, 2023Dhruva et al., JAMA Neurology, 2023 · study
  13. Eldabe et al., Pain Medicine, 2016Eldabe et al., Pain Medicine, 2016 · study
  14. HHS: Your medical recordsHHS: Your medical records · regulator
  15. ABA Model Rule 1.5: feesABA Model Rule 1.5: fees
  16. S.D.N.Y.: How long do I have to file?S.D.N.Y.: How long do I have to file? · court

Checked against 16 primary sources by People's Justice editors · Updated

How we make money

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest